Illumina and Sequoia Capital China selects startups for Genomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Upon completion, Kimberly-Clark shareholders are expected to own about 54% of the combined entity, while Kenvue shareholders will hold the remaining 46%
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Subscribe To Our Newsletter & Stay Updated